Asia Pacific Clinical Nutrition Market Outlook, 2029

The Asia Pacific Clinical Nutrition Market is estimated to reach a staggering USD 5.2 billion by 2030, driven by rise in demand for clinical nutrition products.

According to publisher, The Asia Pacific clinical nutrition market is a burgeoning giant, fueled by a growing population, rising healthcare awareness, and a surge in chronic diseases. Market Insights: Market Growth Potential: The Asia Pacific clinical nutrition market is estimated to reach a staggering USD 5.2 billion by 2030, boasting . Rapid Economic Development:

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Economic growth in the region is leading to rising disposable incomes, allowing consumers to spend more on healthcare products and services, including clinical nutrition solutions. Example: China's growing middle class is increasingly opting for specialized nutritional products to support their health and well-being. Aging Population: Similar to other regions, Asia Pacific faces a rapidly aging population, particularly in countries like China and Japan. This population segment is more susceptible to age-related health conditions and malnutrition, driving the demand for clinical nutrition products. Example: Specialized protein-fortified oral nutritional supplements are gaining popularity among elderly individuals in the region to combat malnutrition and muscle loss. Increasing Disease Burden: The prevalence of chronic diseases like diabetes, cancer, and cardiovascular diseases is rising across Asia Pacific. Clinical nutrition plays a crucial role in managing these conditions by providing targeted dietary support. Example: Enteral feeding tubes can be used for patients with digestive issues or undergoing cancer treatment in India, ensuring they receive the necessary nutrients for recovery. Market Dynamics

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

The Asia Pacific clinical nutrition market is a dynamic environment shaped by several key trends: Focus on Localization: Asian companies are developing and manufacturing clinical nutrition products specifically tailored to the regional market, considering local dietary preferences, cultural nuances, and prevalent health conditions. Example: A Japanese company might develop an enteral formula with a lower lactose content to cater to lactose-intolerant patients common in the region.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

Government Initiatives: Governments in the region are increasingly recognizing the role of clinical nutrition in improving public health. This is leading to initiatives that promote awareness and encourage the adoption of clinical nutrition solutions. Example: The Indian government might launch programs to educate healthcare professionals on the benefits of using oral nutritional supplements for malnourished children. Rise of E-commerce: The e-commerce boom in Asia Pacific is impacting the clinical nutrition market. Patients can now conveniently purchase oral nutritional supplements and other products online. Example: China has a thriving online marketplace for healthcare products, including clinical nutrition solutions. Market Segments The Asia Pacific clinical nutrition market can be segmented based on various criteria: Product Type: The market offers a wide range of clinical nutrition products, including enteral nutrition, parenteral nutrition, and oral nutritional supplements. Application: Clinical nutrition products cater to various medical conditions, such as malnutrition, cancer, gastrointestinal disorders, and surgical recovery. Regional Analysis The Asia Pacific clinical nutrition market exhibits significant variations across different regions: East Asia: East Asia, particularly China, Japan, and South Korea, is the dominant market leader due to a strong healthcare infrastructure, high disease burden, and government support for clinical nutrition. Example: South Korea has a high number of elderly individuals, leading to a strong demand for specialized nutritional products for this population segment. South Asia: South Asia, led by India, is a rapidly growing market due to a rising middle class, increasing disposable incomes, and a growing awareness of health and wellness. Example: Indian companies are developing affordable oral nutritional supplements to address the issue of malnutrition, particularly among children. Southeast Asia: Southeast Asia is an emerging market with significant potential for future growth. As the region's healthcare infrastructure continues to develop and disposable incomes rise, the demand for clinical nutrition products is expected to increase. Example: Countries like Thailand and Vietnam are witnessing investments in healthcare facilities, which will likely drive the demand for clinical nutrition solutions in the coming years. Key Developments The Asia Pacific clinical nutrition market is experiencing continuous innovation: Telehealth Integration: Similar to other regions, telehealth platforms are being integrated with clinical nutrition management in Asia Pacific. This allows for remote patient monitoring and dietary consultations with dietitians. Example: A patient recovering from surgery in a remote area of China might connect with a dietitian virtually for personalized dietary advice and recommendations for suitable clinical nutrition products. Considering the economic disparities within the region, affordability is a key concern. Manufacturers are developing cost-effective clinical nutrition solutions to cater to a wider population. Example: Indian companies are introducing generic versions of enteral feeding formulas to make these essential products more accessible to patients in need. Rise of Direct-to-Consumer Models: There's a growing trend of direct-to-consumer (D2C) models for clinical nutrition products, particularly oral nutritional supplements. This allows for convenient online purchase and delivery directly to patients' homes. Example: A Singaporean startup might offer a subscription service for personalized oral nutritional supplement blends tailored to address specific health concerns. Competitive Landscape The Asia Pacific clinical nutrition market is a competitive landscape with a mix of established multinational players, regional giants, and emerging startups: Multinational Companies: Major global players like Nestle, Abbott Laboratories, and Baxter International have a strong presence in the region, offering a comprehensive range of clinical nutrition products. Example: Abbott Laboratories might establish manufacturing facilities in India to cater to the growing demand for affordable clinical nutrition solutions. Regional Players: Regional giants like Ajinomoto (Japan), Yiling Pharmaceutical (China), and Dabur (India) are playing a significant role, offering localized products and catering to specific regional needs. Example: Yiling Pharmaceutical might develop an enteral feeding formula with traditional Chinese herbs to cater to patient preferences in China. Emerging Startups: Local startups are emerging with innovative solutions tailored to the Asian market. Example: A Vietnamese startup might develop a mobile app that connects patients with dietitians and allows for online purchase of clinical nutrition products. Conclusion The Asia Pacific clinical nutrition market is brimming with potential. As the region's economic development continues, healthcare awareness grows, and chronic diseases rise, the demand for innovative and effective clinical nutrition solutions is expected to surge. With a focus on localization, affordability, and technological advancements, the Asia Pacific market is poised to become a global leader in clinical nutrition in the years to come.

Table of Contents

  • 1 Introduction 9
  • 1.1 Industry Definition and Research Scope 9
  • 1.1.1 Industry Definition 9
  • 1.1.2 Research Scope 10
  • 1.2 Research Methodology 13
  • 1.2.1 Overview of Market Research Methodology 13
  • 1.2.2 Market Assumption 14
  • 1.2.3 Secondary Data 14
  • 1.2.4 Primary Data 14
  • 1.2.5 Data Filtration and Model Design 15
  • 1.2.6 Market Size/Share Estimation 16
  • 1.2.7 Research Limitations 17
  • 1.3 Executive Summary 18
  • 2 Market Overview and Dynamics 21
  • 2.1 Market Size and Forecast 21
  • 2.1.1 Impact of COVID-19 on World Economy 22
  • 2.1.2 Impact of COVID-19 on the Market 25
  • 2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 27
  • 2.2 Major Growth Drivers 31
  • 2.3 Market Restraints and Challenges 37
  • 2.4 Emerging Opportunities and Market Trends 40
  • 2.5 Porter’s Fiver Forces Analysis 44
  • 3 Segmentation of Asia Pacific Market by Substrate 48
  • 3.1 Market Overview by Substrate 48
  • 3.2 Carbohydrates 50
  • 3.3 Lipids 51
  • 3.4 Proteins & Amino Acids 52
  • 3.5 Water & Electrolyte 53
  • 3.6 Dietary Fiber 54
  • 3.7 Antioxidants 55
  • 3.8 Other Substrates 56
  • 4 Segmentation of Asia Pacific Market by Administration Route 57
  • 4.1 Market Overview by Administration Route 57
  • 4.2 Oral or Enteral Administration 59
  • 4.2.1 Oral Nutrition Supplements 60
  • 4.2.2 Tube Feeding 61
  • 4.3 Parenteral Administration 62
  • 4.3.1 Supplemental Parenteral Nutrition 64
  • 4.3.2 Total Parenteral Nutrition 65
  • 4.3.3 All-in-One System 66
  • 4.3.4 Multiple Bottle System 67
  • 5 Segmentation of Asia Pacific Market by Dosage Form 68
  • 5.1 Market Overview by Dosage Form 68
  • 5.2 Powder 70
  • 5.3 Liquid 71
  • 5.4 Solid and Semi-solid 72
  • 6 Segmentation of Asia Pacific Market by Therapeutic Area 73
  • 6.1 Market Overview by Therapeutic Area 73
  • 6.2 Malnutrition 75
  • 6.3 Metabolic Disorders 76
  • 6.4 Gastrointestinal Disorders 77
  • 6.5 Cancer 78
  • 6.6 Neurology 79
  • 6.7 Renal Diseases 80
  • 6.8 Respiratory Diseases 81
  • 6.9 Other Therapeutic Areas 82
  • 7 Segmentation of Asia Pacific Market by End User 83
  • 7.1 Market Overview by End User 83
  • 7.2 Infant 85
  • 7.3 Children 86
  • 7.4 Adult 87
  • 7.5 Geriatrics 88
  • 8 Segmentation of Asia Pacific Market by Healthcare Setting 89
  • 8.1 Market Overview by Healthcare Setting 89
  • 8.2 Hospitals 91
  • 8.3 Long-term Care Facilities (LTC) 92
  • 8.4 Homecare 93
  • 8.5 Inpatient Rehabilitation Facilities 94
  • 8.6 Other Healthcare Settings 95
  • 9 Segmentation of Asia Pacific Market by Distribution Channel 96
  • 9.1 Market Overview by Distribution Channel 96
  • 9.2 Institutional Sales 98
  • 9.3 Supermarkets & Hypermarkets 99
  • 9.4 Pharmacies 100
  • 9.5 Drug Stores 101
  • 9.6 Online Channels 102
  • 9.7 Other Distribution Channels 103
  • 10 Asia-Pacific Market 2022-2032 by Country 104
  • 10.1 Overview of Asia-Pacific Market 104
  • 10.2 Japan 107
  • 10.3 China 110
  • 10.4 Australia 112
  • 10.5 India 114
  • 10.6 South Korea 116
  • 10.7 Rest of APAC Region 118
  • 11 Competitive Landscape 120
  • 11.1 Overview of Key Vendors 120
  • 11.2 New Product Launch, Partnership, Investment, and M&A 123
  • 11.3 Company Profiles 124
  • Abbott Nutrition 124
  • B Braun Melsungen Ag 126
  • BASF SE 129
  • Baxter International Inc. 132
  • Claris Lifesciences Ltd. 135
  • Fresenius Kabi Ag 136
  • Lonza Group AG 139
  • Nestlé S.A. 143
  • Nutricia Ltd 148
  • Perrigo Company Plc 152
  • RELATED REPORTS 155



Table 1. Snapshot of Asia Pacific Clinical Nutrition Market in Balanced Perspective, 2022-2032 19
Table 2. World Economic Outlook, 2021-2031 23
Table 3. World Economic Outlook, 2021-2023 24
Table 4. Scenarios for Economic Impact of Ukraine Crisis 28
Table 5. World Health Spending by Region, $ bn, 2013-2020 36
Table 6. Main Product Trends and Market Opportunities in Asia Pacific Clinical Nutrition Market 40
Table 7. Asia Pacific Clinical Nutrition Market by Substrate, 2022-2032, $ mn 48
Table 8. Asia Pacific Clinical Nutrition Market by Administration Route, 2022-2032, $ mn 57
Table 9. Asia Pacific Clinical Nutrition Market: Oral or Enteral Administration by Type, 2022-2032, $ mn 59
Table 10. Asia Pacific Clinical Nutrition Market: Parenteral Administration by Type, 2022-2032, $ mn 63
Table 11. Asia Pacific Clinical Nutrition Market by Dosage Form, 2022-2032, $ mn 68
Table 12. Asia Pacific Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn 73
Table 13. Asia Pacific Clinical Nutrition Market by End User, 2022-2032, $ mn 83
Table 14. Asia Pacific Clinical Nutrition Market by Healthcare Setting, 2022-2032, $ mn 89
Table 15. Asia Pacific Clinical Nutrition Market by Distribution Channel, 2022-2032, $ mn 96
Table 16. APAC Clinical Nutrition Market by Country, 2022-2032, $ mn 105
Table 17. Japan Clinical Nutrition Market by Administration Route, 2022-2032, $ mn 109
Table 18. Japan Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn 109
Table 19. Japan Clinical Nutrition Market by End User, 2022-2032, $ mn 109
Table 20. China Clinical Nutrition Market by Administration Route, 2022-2032, $ mn 111
Table 21. China Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn 111
Table 22. China Clinical Nutrition Market by End User, 2022-2032, $ mn 111
Table 23. Australia Clinical Nutrition Market by Administration Route, 2022-2032, $ mn 113
Table 24. Australia Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn 113
Table 25. Australia Clinical Nutrition Market by End User, 2022-2032, $ mn 113
Table 26. India Clinical Nutrition Market by Administration Route, 2022-2032, $ mn 115
Table 27. India Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn 115
Table 28. India Clinical Nutrition Market by End User, 2022-2032, $ mn 115
Table 29. South Korea Clinical Nutrition Market by Administration Route, 2022-2032, $ mn 117
Table 30. South Korea Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn 117
Table 31. South Korea Clinical Nutrition Market by End User, 2022-2032, $ mn 117
Table 32. Clinical Nutrition Market in Rest of APAC by Country/Region, 2022-2032, $ mn 119
Table 33. Abbott Nutrition: Company Snapshot 124
Table 34. Abbott Nutrition: Business Segmentation 125
Table 35. Abbott Nutrition: Product Portfolio 125
Table 36. B Braun Melsungen Ag: Company Snapshot 126
Table 37. B Braun Melsungen Ag: Business Segmentation 127
Table 38. B Braun Melsungen Ag: Revenue by Region 127
Table 39. B Braun Melsungen Ag: Product Portfolio 128
Table 40. BASF: Company Snapshot 129
Table 41. BASF: Business Segmentation 130
Table 42. BASF: Revenue by Region 130
Table 43. BASF: Product Portfolio 131
Table 44. Baxter International Inc.: Company Snapshot 132
Table 45. Baxter International Inc.: Business Segmentation 132
Table 46. Baxter International Inc.: Revenue by Region 133
Table 47. Baxter International Inc.: Product Portfolio 133
Table 48. Claris Lifesciences Ltd.: Company Snapshot 135
Table 49. Fresenius Kabi Ag: Company Snapshot 136
Table 50. Fresenius Kabi Ag: Business Segmentation 137
Table 51. Fresenius Kabi Ag: Revenue by Region 137
Table 52. Fresenius Kabi Ag: Product Portfolio 138
Table 53. Lonza Group: Company Snapshot 139
Table 54. Lonza Group: Business Segmentation in 2018 140
Table 55. Lonza Group: Product Portfolio 140
Table 56. Lonza Group: Revenue by Region in 2018 141
Table 57. Nestlé S.A.: Company Snapshot 143
Table 58. Nestlé S.A.: Business Segmentation 143
Table 59. Nestlé S.A.: Product Portfolio 144
Table 60. Nestlé S.A.: Revenue, 2018-2020, $ bn 146
Table 61. Nutricia Ltd: Company Snapshot 148
Table 62. Nutricia Ltd: Business Segmentation 149
Table 63. Nutricia Ltd: Revenue by Region 149
Table 64. Nutricia Ltd: Product Portfolio 150
Table 65. Perrigo Company Plc: Company Snapshot 152
Table 66. Perrigo Company Plc: Business Segmentation 153
Table 67. Perrigo Company Plc: Revenue by Region 153
Table 68. Perrigo Company Plc: Product Portfolio 153



Figure 1. Research Method Flow Chart 13
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 16
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032 18
Figure 4. Asia Pacific Clinical Nutrition Market, 2022-2032, $ mn 21
Figure 5. Impact of COVID-19 on Business 25
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Clinical Nutrition Market 31
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million 34
Figure 8. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million 35
Figure 9. Forecast of World Middle-class Population by Region, 2015-2030, million 35
Figure 10. Primary Restraints and Impact Factors of Asia Pacific Clinical Nutrition Market 37
Figure 11. Investment Opportunity Analysis 41
Figure 12. Porter’s Fiver Forces Analysis of Asia Pacific Clinical Nutrition Market 44
Figure 13. Breakdown of Asia Pacific Clinical Nutrition Market by Substrate, 2022-2032, % of Revenue 49
Figure 14. Asia Pacific Addressable Market Cap in 2023-2032 by Substrate, Value ($ mn) and Share (%) 49
Figure 15. Asia Pacific Clinical Nutrition Market by Substrate: Carbohydrates, 2022-2032, $ mn 50
Figure 16. Asia Pacific Clinical Nutrition Market by Substrate: Lipids, 2022-2032, $ mn 51
Figure 17. Asia Pacific Clinical Nutrition Market by Substrate: Proteins & Amino Acids, 2022-2032, $ mn 52
Figure 18. Asia Pacific Clinical Nutrition Market by Substrate: Water & Electrolyte, 2022-2032, $ mn 53
Figure 19. Asia Pacific Clinical Nutrition Market by Substrate: Dietary Fiber, 2022-2032, $ mn 54
Figure 20. Asia Pacific Clinical Nutrition Market by Substrate: Antioxidants, 2022-2032, $ mn 55
Figure 21. Asia Pacific Clinical Nutrition Market by Substrate: Other Substrates, 2022-2032, $ mn 56
Figure 22. Breakdown of Asia Pacific Clinical Nutrition Market by Administration Route, 2022-2032, % of Sales Revenue 58
Figure 23. Asia Pacific Addressable Market Cap in 2023-2032 by Administration Route, Value ($ mn) and Share (%) 58
Figure 24. Asia Pacific Clinical Nutrition Market by Administration Route: Oral or Enteral Administration, 2022-2032, $ mn 59
Figure 25. Asia Pacific Clinical Nutrition Market by Oral or Enteral Administration: Oral Nutrition Supplements, 2022-2032, $ mn 60
Figure 26. Asia Pacific Clinical Nutrition Market by Oral or Enteral Administration: Tube Feeding, 2022-2032, $ mn 61
Figure 27. Asia Pacific Clinical Nutrition Market by Administration Route: Parenteral Administration, 2022-2032, $ mn 62
Figure 28. Asia Pacific Clinical Nutrition Market by Parenteral Administration: Supplemental Parenteral Nutrition, 2022-2032, $ mn 64
Figure 29. Asia Pacific Clinical Nutrition Market by Parenteral Administration: Total Parenteral Nutrition, 2022-2032, $ mn 65
Figure 30. Asia Pacific Clinical Nutrition Market by Parenteral Administration: All-in-One System, 2022-2032, $ mn 66
Figure 31. Asia Pacific Clinical Nutrition Market by Parenteral Administration: Multiple Bottle System, 2022-2032, $ mn 67
Figure 32. Breakdown of Asia Pacific Clinical Nutrition Market by Dosage Form, 2022-2032, % of Sales Revenue 69
Figure 33. Asia Pacific Addressable Market Cap in 2023-2032 by Dosage Form, Value ($ mn) and Share (%) 69
Figure 34. Asia Pacific Clinical Nutrition Market by Dosage Form: Powder, 2022-2032, $ mn 70
Figure 35. Asia Pacific Clinical Nutrition Market by Dosage Form: Liquid, 2022-2032, $ mn 71
Figure 36. Asia Pacific Clinical Nutrition Market by Dosage Form: Solid and Semi-solid, 2022-2032, $ mn 72
Figure 37. Breakdown of Asia Pacific Clinical Nutrition Market by Therapeutic Area, 2022-2032, % of Revenue 74
Figure 38. Asia Pacific Addressable Market Cap in 2023-2032 by Therapeutic Area, Value ($ mn) and Share (%) 74
Figure 39. Asia Pacific Clinical Nutrition Market by Therapeutic Area: Malnutrition, 2022-2032, $ mn 75
Figure 40. Asia Pacific Clinical Nutrition Market by Therapeutic Area: Metabolic Disorders, 2022-2032, $ mn 76
Figure 41. Asia Pacific Clinical Nutrition Market by Therapeutic Area: Gastrointestinal Disorders, 2022-2032, $ mn 77
Figure 42. Asia Pacific Clinical Nutrition Market by Therapeutic Area: Cancer, 2022-2032, $ mn 78
Figure 43. Asia Pacific Clinical Nutrition Market by Therapeutic Area: Neurology, 2022-2032, $ mn 79
Figure 44. Asia Pacific Clinical Nutrition Market by Therapeutic Area: Renal Diseases, 2022-2032, $ mn 80
Figure 45. Asia Pacific Clinical Nutrition Market by Therapeutic Area: Respiratory Diseases, 2022-2032, $ mn 81
Figure 46. Asia Pacific Clinical Nutrition Market by Therapeutic Area: Other Therapeutic Areas, 2022-2032, $ mn 82
Figure 47. Breakdown of Asia Pacific Clinical Nutrition Market by End User, 2022-2032, % of Revenue 84
Figure 48. Asia Pacific Addressable Market Cap in 2023-2032 by End User, Value ($ mn) and Share (%) 84
Figure 49. Asia Pacific Clinical Nutrition Market by End User: Infant, 2022-2032, $ mn 85
Figure 50. Asia Pacific Clinical Nutrition Market by End User: Children, 2022-2032, $ mn 86
Figure 51. Asia Pacific Clinical Nutrition Market by End User: Adult, 2022-2032, $ mn 87
Figure 52. Asia Pacific Clinical Nutrition Market by End User: Geriatrics, 2022-2032, $ mn 88
Figure 53. Breakdown of Asia Pacific Clinical Nutrition Market by Healthcare Setting, 2022-2032, % of Revenue 89
Figure 54. Asia Pacific Addressable Market Cap in 2023-2032 by Healthcare Setting, Value ($ mn) and Share (%) 90
Figure 55. Asia Pacific Clinical Nutrition Market by Healthcare Setting: Hospitals, 2022-2032, $ mn 91
Figure 56. Asia Pacific Clinical Nutrition Market by Healthcare Setting: Long-term Care Facilities (LTC), 2022-2032, $ mn 92
Figure 57. Asia Pacific Clinical Nutrition Market by Healthcare Setting: Homecare, 2022-2032, $ mn 93
Figure 58. Asia Pacific Clinical Nutrition Market by Healthcare Setting: Inpatient Rehabilitation Facilities, 2022-2032, $ mn 94
Figure 59. Asia Pacific Clinical Nutrition Market by Healthcare Setting: Other Healthcare Settings, 2022-2032, $ mn 95
Figure 60. Breakdown of Asia Pacific Clinical Nutrition Market by Distribution Channel, 2022-2032, % of Revenue 97
Figure 61. Asia Pacific Addressable Market Cap in 2023-2032 by Distribution Channel, Value ($ mn) and Share (%) 97
Figure 62. Asia Pacific Clinical Nutrition Market by Distribution Channel: Institutional Sales, 2022-2032, $ mn 98
Figure 63. Asia Pacific Clinical Nutrition Market by Distribution Channel: Supermarkets & Hypermarkets, 2022-2032, $ mn 99
Figure 64. Asia Pacific Clinical Nutrition Market by Distribution Channel: Pharmacies, 2022-2032, $ mn 100
Figure 65. Asia Pacific Clinical Nutrition Market by Distribution Channel: Drug Stores, 2022-2032, $ mn 101
Figure 66. Asia Pacific Clinical Nutrition Market by Distribution Channel: Online Channels, 2022-2032, $ mn 102
Figure 67. Asia Pacific Clinical Nutrition Market by Distribution Channel: Other Distribution Channels, 2022-2032, $ mn 103
Figure 68. Breakdown of APAC Clinical Nutrition Market by Country, 2022 and 2032, % of Revenue 105
Figure 69. Contribution to APAC 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%) 106
Figure 70. Clinical Nutrition Market in Japan, 2022-2032, $ mn 108
Figure 71. Clinical Nutrition Market in China, 2022-2032, $ mn 110
Figure 72. Clinical Nutrition Market in Australia, 2022-2032, $ mn 112
Figure 73. Clinical Nutrition Market in India, 2022-2032, $ mn 114
Figure 74. Clinical Nutrition Market in South Korea, 2022-2032, $ mn 116
Figure 75. Clinical Nutrition Market in Rest of APAC, 2022-2032, $ mn 118
Figure 76. Growth Stage of Asia Pacific Clinical Nutrition Industry over the Forecast Period 120
Figure 77. Nestlé S.A.: Revenue by Region, 2018 146
Logo

Asia Pacific Clinical Nutrition Market Outlook, 2029

Contact usWe are friendly and approachable, give us a call.